BFB-759

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameBFB-759
Drug Alias NameBFB759BFB-759
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis, AtopicHidradenitis Suppurativa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBluefin Biomedicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBluefin Biomedicine Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicHidradenitis Suppurativa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A